$ABCL

$12.68 +$0.60 (4.93%) Live

$ABCL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ABCL Management Team

Dr. Carl Hansen

Chairman of the Board

President

Chief Executive Officer

Co-Founder

Age 50

Compensation $8.245M USD

Sex Male

Mr. Andrew Booth

Chief Financial Officer

Age 51

Compensation $3.429M USD

Sex Male

Dr. Veronique Lecault

Co-Founder

Chief Operating Officer

Director

Age 40

Compensation $3.425M USD

Sex Female

Mr. Tryn Stimart

Chief Legal Officer

Chief Compliance Officer

Corporate Secretary and Privacy Officer

Age 55

Compensation $2.891M USD

Sex Male

Dr. Sarah Noonberg

Chief Medical Officer

Age 57

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Carl Hansen Chairman of the Board President Chief Executive Officer Co-Founder	50	$8.245M USD	Male
Mr. Andrew Booth Chief Financial Officer	51	$3.429M USD	Male
Dr. Veronique Lecault Co-Founder Chief Operating Officer Director	40	$3.425M USD	Female
Mr. Tryn Stimart Chief Legal Officer Chief Compliance Officer Corporate Secretary and Privacy Officer	55	$2.891M USD	Male
Dr. Sarah Noonberg Chief Medical Officer	57	-	Female

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

3 of 3

stated in the proxy; 2 not stated

Average tenure

7.2 years

from year joined

CEO also chairs the board

Yes

Carl L.G. Hansen, Ph.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
John S. Montalbano, CFA	61	2020 6 years	Independent	Audit Committee · Chair Compensation Committee Nominating and Corporate Governance Committee	Canada Pension Plan Investment Board, Manulife Financial Corporation	$558,861
Stephen R. Quake, D.Phil.	56	2025 1 year	Independent	None stated	Tachyon Therapeutics, IgGenix Inc., Superfluid DX, ClearNote Health, Kanvas, Mirvie	$437,491
Véronique Lecault, Ph.D. Executive officer	41	2018 8 years	Not stated	None stated	None stated	Not stated
Carl L.G. Hansen, Ph.D. Board chair, CEO	51	2012 14 years	Not stated	None stated	None stated	Paid as CEO
Michael Hayden, MBCHB (M.D.), Ph.D. Lead independent director	74	2019 7 years	Independent	Compensation Committee · Chair Nominating and Corporate Governance Committee Audit Committee	Ionis Pharmaceuticals Inc., 89bio, Inc.	$586,361

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$ABCL Management Team

Dr. Carl Hansen

Mr. Andrew Booth

Dr. Veronique Lecault

Mr. Tryn Stimart

Dr. Sarah Noonberg

Board of Directors

Related-party transactions

No related-party transactions disclosed